0001250853-13-000072.txt : 20130502 0001250853-13-000072.hdr.sgml : 20130502 20130502185725 ACCESSION NUMBER: 0001250853-13-000072 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130430 FILED AS OF DATE: 20130502 DATE AS OF CHANGE: 20130502 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RXi Pharmaceuticals Corp CENTRAL INDEX KEY: 0001533040 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1500 WEST PARK DRIVE STREET 2: SUITE 210 CITY: WESTBOROUGH STATE: MA ZIP: 01581 BUSINESS PHONE: (508) 767-3861 MAIL ADDRESS: STREET 1: 1500 WEST PARK DRIVE STREET 2: SUITE 210 CITY: WESTBOROUGH STATE: MA ZIP: 01581 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Galena Biopharma, Inc. CENTRAL INDEX KEY: 0001390478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-54910 FILM NUMBER: 13809704 BUSINESS ADDRESS: STREET 1: 310 N. STATE STREET STREET 2: SUITE 208 CITY: LAKE OSWEGO STATE: OR ZIP: 97034 BUSINESS PHONE: 855 855 GALE MAIL ADDRESS: STREET 1: 310 N. STATE STREET STREET 2: SUITE 208 CITY: LAKE OSWEGO STATE: OR ZIP: 97034 FORMER NAME: FORMER CONFORMED NAME: RXi Pharmaceuticals Corp DATE OF NAME CHANGE: 20110926 FORMER NAME: FORMER CONFORMED NAME: GALENA BIOPHARMA, INC. DATE OF NAME CHANGE: 20110922 FORMER NAME: FORMER CONFORMED NAME: RXI PHARMACEUTICALS CORP DATE OF NAME CHANGE: 20110921 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2013-04-30 1 0001533040 RXi Pharmaceuticals Corp RXII 0001390478 Galena Biopharma, Inc. 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034 0 0 1 0 Common Stock, $0.0001 par value 2013-04-30 4 S 0 171000 0.2138 D 33305595 D Common Stock, $0.0001 par value 2013-05-01 4 S 0 659500 0.1925 D 32646095 D Common Stock, $0.0001 par value 2013-05-02 4 S 0 253000 0.1905 D 32393095 D The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $0.21 to $0.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $0.19 to $0.21, inclusive. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $0.19 to $0.1905, inclusive. Galena Biopharma, Inc., By: /s/ Ryan M. Dunlap, Director of Finance, Controller 2013-05-02